QMS Medical Allied Services LtdQ4 FY25
QMS Medical Allied Services Ltd Q4 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹95.3P/E: 14.8Market Cap: ₹174 CrSector: Healthcare Equipment & Supplies
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 2- →The company aims to grow its patient service programs to INR 100 crores over the next three years, up from current INR 15-20 crores annually.
- →Growth includes acquisition of a similar-sized company expected to double the patient services segment.
- →Product business is targeted to grow at a steady rate of approximately 15% annually.
- →Focus on expanding the number of field technicians and dietitians to meet growing demand in patient services.
- →Online sales to increase gradually by expanding product portfolio beyond current limited range, focusing on wellness and fitness sectors.
- →The company plans to scale monthly revenues of own brands and patient services, aiming to double current monthly revenues in about a year.
- →Emphasis on sustainable EBITDA margins through higher-margin patient service camps and direct import of products.
- →Overall, the company is bullish on patient service programs and QDevices brand growth over the next 2-3 years.
Margin guidance
Category 3- →The company focuses on achieving steady growth over the next 2-3 years rather than projecting long-term 5-year targets due to dynamic business conditions.
- →Patient service programs are expected to triple in size post-acquisition within the next three years.
- →Product business aims for a standard growth rate of approximately 15% annually.
- →EBITDA margins are expected to stabilize and improve from next year onwards as operational expenditures settle.
- →The company is optimistic about scaling patient service programs significantly, viewing them as a key future growth driver.
- →EPS showed a 37.9% growth over 9-month FY24 compared to the previous year, reflecting positive financial management and strategic initiatives.
- →No specific 5-year revenue or profit targets were outlined; focus remains on 2-3 year projections with ongoing revisions based on market conditions.
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →The company is currently undertaking a preferential allotment (equity fundraising) to acquire a patient service programs company.
- →Due diligence and discussions regarding this acquisition are ongoing, with the announcement expected soon, possibly within the current quarter.
- →The funds raised through the preferential allotment will be used primarily for this acquisition.
- →For expanding the QDevices brand, capital is expected to come from existing revenue streams, not requiring additional capital raise.
- →There is no explicit mention of new debt fundraising in the provided excerpts.
- →The company focuses on growing both patient service programs and product business organically along with acquisitions funded through equity.
Order book
- →Current corporates provide enough scope for orders within pharma divisions, with around 30 divisions per company acting like separate companies.
- →There is significant demand in the existing market plus new opportunities in insurance and other sectors.
- →The existing order flow is sufficient to keep operations running full-scale.
- →The company is increasing field technicians and dietitians to meet growing demand, conducting about 100 camps daily across 78 cities.
- →An acquisition is underway expected to bring in additional order volume, roughly doubling patient services revenue from INR15-20 crores to INR100 crores in three years.
- →The business model receives bookings via an app from corporate clients which schedule camps at various doctor clinics.
- →Overall, order inflow and orderbook look healthy with a mix of existing corporate expansions and new business segments.
Capex plans
Yes- →The company has invested approximately INR 15 to 20 crores as capex, primarily towards equipment for Patient Service Camps. Each representative carries machinery worth INR 15 to 17 lakhs.
- →A significant capex has been brought in for the cancer model as part of new product efforts.
- →The focus is on increasing the number of technicians and field staff with devices over the next six to eight months to meet high demand.
- →Capital expenditures also support expansion in patient service programs and product business growth.
- →The company is pursuing acquisitions in the patient services business; due diligence is ongoing with announcements expected in the current quarter.
- →Strategic import of products under their own registration from CDSO has begun, to improve margins and reduce dependency on local vendors.
- →Efforts include expansion of the QDevices brand, increasing online presence, and adding wellness and fitness products.
How does QMS Medical Allied Services Ltd rank vs peers in Healthcare Equipment & Supplies?
Pro feature1QMS Medical Allied Services Ltd
Rev 2Mar 3
See full Healthcare Equipment & Supplies sector rankings
Want more stocks like QMS Medical Allied Services Ltd?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio